Burn-X, magensaftresistente Tabletten
7680688140118
Pharmacode 1034352
CH-68814
A02BC05
04.99.0.
Active substances:
1 / 3
google
Details
- GTIN
- 7680688140118
- Pharmacode
- 1034352
- Product number
- 6881401
- CPT
- -
- Packaging group
- 7
- Unit
- Tablette(n)
- Composition
- esomeprazolum 20 mg ut esomeprazolum magnesicum dihydricum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas, polysorbatum 80, talcum, triethylis citras, hypromellosum, sacchari sphaerae, magnesii stearas, hydroxypropylcellulosum, glyceroli monostearas 40-55, polysorbatum 80, cellulosum microcristallinum, povidonum, macrogolum 6000, crospovidonum, natrii stearylis fumaras, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (rubrum), E 172 (flavum) pro compresso obducto corresp. natrium 0.082 mg.
Articles (1)
Burn-X, magensaftresistente Tabletten
Magensaftresistente Tabletten
7
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
esomeprazolum
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
esomeprazolum magnesicum dihydricum
|
- | Substance | WIZUS |
|
acidi methacrylici et ethylis acrylatis polymerisatum 1:1
|
- | Substance | HNIDK |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
triethylis citras
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
sacchari sphaerae
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
hydroxypropylcellulosum
|
- | Substance | HNIDK |
|
glyceroli monostearas 40-55
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
povidonum
|
- | Substance | HNIDK |
|
macrogolum 6000
|
- | Substance | HNIDK |
|
crospovidonum
|
- | Substance | HNIDK |
|
natrii stearylis fumaras
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
macrogolum 400
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
E 172 (rubrum)
|
- | Substance | FTODK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
natrium
|
0.082 MG | Substance | HBESI |
Authorization holder
axapharm ag
6340 Baar
Authorization information
- Swissmedic authorization number
- 68814
- Drug name
- Burn-X, magensaftresistente Tabletten
- Galenic form
- MATB
- ATC Code
- A02BC05
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 17/02/2022
- Authorization expiration date
- 01/09/2026
- IT number
- 04.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BURN-X cpr pell 20 mg 7 pce
- Description (DE)
- BURN-X Filmtabl 20 mg 7 Stk
- Market launch
- 17/02/2022
- Market withdrawal
- 30/08/2026
- Narcotic (BTM)
- No